UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

CHARGING TIME

Iowa law review, 2023-05, Vol.108 (4), p.1723-1780

2023

Volltextzugriff (PDF)

Fear of Adversariness: Using Gideon To Restrict Defendants' Invocation of Adversary Procedures

The Yale law journal, 2013-06, Vol.122 (8), p.2550-2577

METZGER, PAMELA R.

2013

Volltextzugriff (PDF)

Cheating the Constitution

Vanderbilt law review, 2006-03, Vol.59 (2), p.475

Metzger, Pamela R

2006

Volltextzugriff (PDF)

CONFRONTATION AS A RULE OF PRODUCTION

The William and Mary Bill of Rights journal, 2016-05, Vol.24 (4), p.995

Metzger, Pamela R

2016

Volltextzugriff (PDF)

Me and Mr. Jones: a systems-based analysis of a catastrophic defense outcome

Albany law review, 2015-03, Vol.78 (3), p.1261

Metzger, Pamela R

2015

Volltextzugriff (PDF)

Beyond the bright line: A contemporary right-to-counsel doctrine

Northwestern University law review, 2003-07, Vol.97 (4), p.1635

Metzger, Pamela R

2003

Volltextzugriff (PDF)

Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2016-07, Vol.316 (2), p.156

2016

Volltextzugriff (PDF)

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

Diabetes care, 2021-12, Vol.44 (12), p.2775-2782

2021

Volltextzugriff (PDF)

Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats

Scientific reports, 2019-05, Vol.9 (1), p.7936-7936, Article 7936

2019

Volltextzugriff (PDF)

Lessons learned after 20 years of real-world experience with natalizumab

Multiple sclerosis and related disorders, 2023-12, Vol.80, p.105048-105048, Article 105048

2023

Volltextzugriff (PDF)

Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study

Diabetic medicine, 2013-01, Vol.30 (1), p.46-55

2013

Volltextzugriff (PDF)

Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience

Diabetes care, 2022-11, Vol.45 (11), p.2653-2661

2022

Volltextzugriff (PDF)

Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study

The Lancet (British edition), 2012-06, Vol.379 (9833), p.2243-2251

2012

Volltextzugriff (PDF)

Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP)

Diabetes (New York, N.Y.), 2023-08, Vol.72 (8), p.1161-1172

2023

Volltextzugriff (PDF)

Association of Metformin With the Development of Age-Related Macular Degeneration

JAMA ophthalmology, 2023-02, Vol.141 (2), p.140

2023

Volltextzugriff (PDF)

Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure

Diabetes care, 2024-05, Vol.47 (5), p.810

2024

Volltextzugriff (PDF)

Genetic Predictors of Weight Loss and Weight Regain After Intensive Lifestyle Modification, Metformin Treatment, or Standard Care in the Diabetes Prevention Program

Diabetes care, 2012-02, Vol.35 (2), p.363-366

2012

Volltextzugriff (PDF)

Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence

The international journal of behavioral nutrition and physical activity, 2014-02, Vol.11 (1), p.16-16, Article 16

2014

Volltextzugriff (PDF)

The Navy's Application of Ocean Forecasting to Decision Support

Oceanography (Washington, D.C.), 2014-09, Vol.27 (3), p.126-137

2014

Volltextzugriff (PDF)

The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program

Diabetes care, 2012-09, Vol.35 (9), p.1864-1867

2012

Volltextzugriff (PDF)

RELMβ/FIZZ2 Is a Goblet Cell-Specific Immune-Effector Molecule in the Gastrointestinal Tract

Proceedings of the National Academy of Sciences - PNAS, 2004-09, Vol.101 (37), p.13596-13600

2004

Volltextzugriff (PDF)

Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program

PloS one, 2012-09, Vol.7 (9), p.e44424-e44424

2012

Volltextzugriff (PDF)

Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program

Diabetologia, 2014-03, Vol.57 (3), p.485-490

2014

Volltextzugriff (PDF)

Extension of Type 2 Diabetes Genome-Wide Association Scan Results in the Diabetes Prevention Program

Diabetes (New York, N.Y.), 2008-09, Vol.57 (9), p.2503-2510

2008

Volltextzugriff (PDF)

First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes

International Journal of Obesity, 2008-10, Vol.32 (10), p.1537-1544

2008

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Humans
(26)
Life Sciences & Biomedicine
(26)
Diabetes
(22)
Female
(18)
Male
(17)
Middle Aged
(16)
Diabetes Mellitus, Type 2 - Prevention & Control
(15)
Lifestyles
(15)
Endocrinology & Metabolism
(14)
Adult
(13)
Metformin - Therapeutic Use
(13)
Prevention Programs
(13)
Glucose
(12)
Life Style
(12)
Diabetes Mellitus
(10)
Metformin
(10)
Prevention
(10)
Biological And Medical Sciences
(9)
Body Mass Index
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CHARGING TIME

Fear of Adversariness: Using Gideon To Restrict Defendants' Invocation of Adversary Procedures

Cheating the Constitution

CONFRONTATION AS A RULE OF PRODUCTION

Me and Mr. Jones: a systems-based analysis of a catastrophic defense outcome

Beyond the bright line: A contemporary right-to-counsel doctrine

Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial

Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study

Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats

Lessons learned after 20 years of real-world experience with natalizumab

Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study

Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience

Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study

Identification of Genetic Variation Influencing Metformin Response in a Multiancestry Genome-Wide Association Study in the Diabetes Prevention Program (DPP)

Association of Metformin With the Development of Age-Related Macular Degeneration

Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure

Genetic Predictors of Weight Loss and Weight Regain After Intensive Lifestyle Modification, Metformin Treatment, or Standard Care in the Diabetes Prevention Program

Short and long-term lifestyle coaching approaches used to address diverse participant barriers to weight loss and physical activity adherence

The Navy's Application of Ocean Forecasting to Decision Support

The C allele of ATM rs11212617 does not associate with metformin response in the Diabetes Prevention Program

RELMβ/FIZZ2 Is a Goblet Cell-Specific Immune-Effector Molecule in the Gastrointestinal Tract

Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program

Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program

Extension of Type 2 Diabetes Genome-Wide Association Scan Results in the Diabetes Prevention Program

First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes

Suchergebnisse filtern